These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 21372597)

  • 1. Significance of DNA polymerase delta catalytic subunit p125 induced by mutant p53 in the invasive potential of human hepatocellular carcinoma.
    Sanefuji K; Taketomi A; Iguchi T; Sugimachi K; Ikegami T; Yamashita Y; Gion T; Soejima Y; Shirabe K; Maehara Y
    Oncology; 2010; 79(3-4):229-37. PubMed ID: 21372597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased expression of Wiskott-Aldrich syndrome protein family verprolin-homologous protein 2 correlated with poor prognosis of hepatocellular carcinoma.
    Yang LY; Tao YM; Ou DP; Wang W; Chang ZG; Wu F
    Clin Cancer Res; 2006 Oct; 12(19):5673-9. PubMed ID: 17020969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased expression of ING2 gene and its clinicopathological significance in hepatocellular carcinoma.
    Zhang HK; Pan K; Wang H; Weng DS; Song HF; Zhou J; Huang W; Li JJ; Chen MS; Xia JC
    Cancer Lett; 2008 Mar; 261(2):183-92. PubMed ID: 18160212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidermal growth factor-containing fibulin-like extracellular matrix protein 1, EFEMP1, a novel tumor-suppressor gene detected in hepatocellular carcinoma using double combination array analysis.
    Nomoto S; Kanda M; Okamura Y; Nishikawa Y; Qiyong L; Fujii T; Sugimoto H; Takeda S; Nakao A
    Ann Surg Oncol; 2010 Mar; 17(3):923-32. PubMed ID: 19898900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive value of expression and promoter hypermethylation of XAF1 in hepatitis B virus-associated hepatocellular carcinoma treated with transplantation.
    Zhang F; Wu LM; Zhou L; Chen QX; Xie HY; Feng XW; Zheng SS
    Ann Surg Oncol; 2008 Dec; 15(12):3494-502. PubMed ID: 18830757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of cytokeratin 19 in human hepatocellular carcinoma cell lines.
    Wu F; Nishioka M; Fujita J; Murota M; Ohtsuki Y; Ishida T; Kuriyama S
    Int J Oncol; 2002 Jan; 20(1):31-7. PubMed ID: 11743639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant splicing of Hugl-1 is associated with hepatocellular carcinoma progression.
    Lu X; Feng X; Man X; Yang G; Tang L; Du D; Zhang F; Yuan H; Huang Q; Zhang Z; Liu Y; Strand D; Chen Z
    Clin Cancer Res; 2009 May; 15(10):3287-96. PubMed ID: 19447873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased expression of BATF2 is associated with a poor prognosis in hepatocellular carcinoma.
    Ma H; Liang X; Chen Y; Pan K; Sun J; Wang H; Wang Q; Li Y; Zhao J; Li J; Chen M; Xia J
    Int J Cancer; 2011 Feb; 128(4):771-7. PubMed ID: 20473897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased expression of inhibitor of growth 4 correlated with poor prognosis of hepatocellular carcinoma.
    Fang F; Luo LB; Tao YM; Wu F; Yang LY
    Cancer Epidemiol Biomarkers Prev; 2009 Feb; 18(2):409-16. PubMed ID: 19208663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition mechanism of a newly cloned candidate tumor suppressor gene JST during hepatocarcinogenesis and its abnormal expression in human hepatocellular carcinoma from Qidong liver cancer risk area, China.
    Dong-Dong L; Xi-Ran Z
    Hepatogastroenterology; 2004; 51(56):515-25. PubMed ID: 15086194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High levels of p53 protein expression do not correlate with p53 mutations in hepatocellular carcinoma.
    Anzola M; Saiz A; Cuevas N; Lopez-Martinez M; Martinez de Pancorbo MA; Burgos JJ
    J Viral Hepat; 2004 Nov; 11(6):502-10. PubMed ID: 15500550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promoter-hypermethylation is causing functional relevant downregulation of methylthioadenosine phosphorylase (MTAP) expression in hepatocellular carcinoma.
    Hellerbrand C; Mühlbauer M; Wallner S; Schuierer M; Behrmann I; Bataille F; Weiss T; Schölmerich J; Bosserhoff AK
    Carcinogenesis; 2006 Jan; 27(1):64-72. PubMed ID: 16081515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of mutant nuclear beta-catenin correlates with non-invasive hepatocellular carcinoma, absence of portal vein spread, and good prognosis.
    Mao TL; Chu JS; Jeng YM; Lai PL; Hsu HC
    J Pathol; 2001 Jan; 193(1):95-101. PubMed ID: 11169521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of p53 by Notch3 is mediated by Cyclin G1 and sustained by MDM2 and miR-221 axis in hepatocellular carcinoma.
    Giovannini C; Minguzzi M; Baglioni M; Fornari F; Giannone F; Ravaioli M; Cescon M; Chieco P; Bolondi L; Gramantieri L
    Oncotarget; 2014 Nov; 5(21):10607-20. PubMed ID: 25431954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells.
    Fornari F; Gramantieri L; Giovannini C; Veronese A; Ferracin M; Sabbioni S; Calin GA; Grazi GL; Croce CM; Tavolari S; Chieco P; Negrini M; Bolondi L
    Cancer Res; 2009 Jul; 69(14):5761-7. PubMed ID: 19584283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-suppressor effect of interferon regulatory factor-1 in human hepatocellular carcinoma.
    Moriyama Y; Nishiguchi S; Tamori A; Koh N; Yano Y; Kubo S; Hirohashi K; Otani S
    Clin Cancer Res; 2001 May; 7(5):1293-8. PubMed ID: 11350897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of p53 gene in 184 unifocal hepatocellular carcinomas: association with tumor growth and invasiveness.
    Hsu HC; Tseng HJ; Lai PL; Lee PH; Peng SY
    Cancer Res; 1993 Oct; 53(19):4691-4. PubMed ID: 8402647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wilms' tumour 1 gene expression is increased in hepatocellular carcinoma and associated with poor prognosis.
    Sera T; Hiasa Y; Mashiba T; Tokumoto Y; Hirooka M; Konishi I; Matsuura B; Michitaka K; Udaka K; Onji M
    Eur J Cancer; 2008 Mar; 44(4):600-8. PubMed ID: 18255279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of PICT1 in patients of hepatocellular carcinoma with wild-type TP53.
    Ishibashi M; Kogo R; Shibata K; Ueo H; Uchi R; Matsumura T; Takano Y; Sawada G; Takahashi Y; Mima K; Kurashige J; Akiyoshi S; Iwaya T; Eguchi H; Sudo T; Sugimachi K; Suzuki A; Wakabayashi G; Mori M; Mimori K
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S537-44. PubMed ID: 23532381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Receptor activator of nuclear factor-kappaB ligand (RANKL) expression in hepatocellular carcinoma with bone metastasis.
    Sasaki A; Ishikawa K; Haraguchi N; Inoue H; Ishio T; Shibata K; Ohta M; Kitano S; Mori M
    Ann Surg Oncol; 2007 Mar; 14(3):1191-9. PubMed ID: 17195907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.